Clinical Trial Update: QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This update reports on the completed Phase 1/2 study of ALT-801 in combination with cisplatin for metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ALT-801
• CISPLATIN (cisplatin)

Snippet

Sponsor: Altor BioScience | Conditions: Metastatic Melanoma | Phase 1, Phase 2 | Status: COMPLETED